Johnson KA - Search Results

1

Folate intake, alcohol use, and postmenopausal breast cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.

Stolzenberg-Solomon RZ, Chang SC, Leitzmann MF, Johnson KA, Johnson C, Buys SS, Hoover RN, Ziegler RG. Stolzenberg-Solomon RZ, et al. Among authors: johnson c, johnson ka. Am J Clin Nutr. 2006 Apr;83(4):895-904. doi: 10.1093/ajcn/83.4.895. Am J Clin Nutr. 2006. PMID: 16600944 Free article.

2

Pathologic findings following false-positive screening tests for ovarian cancer in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial.

Nyante SJ, Black A, Kreimer AR, Duggan MA, Carreon JD, Kessel B, Buys SS, Ragard LR, Johnson KA, Dunn BK, Lamerato L, Commins JM, Berg CD, Sherman ME. Nyante SJ, et al. Among authors: johnson ka. Gynecol Oncol. 2011 Mar;120(3):474-9. doi: 10.1016/j.ygyno.2010.11.015. Epub 2010 Dec 7. Gynecol Oncol. 2011. PMID: 21144559 Free PMC article. Clinical Trial.

3

Age, sex, and racial differences in the use of standard adjuvant therapy for colorectal cancer.

Potosky AL, Harlan LC, Kaplan RS, Johnson KA, Lynch CF. Potosky AL, et al. Among authors: johnson ka. J Clin Oncol. 2002 Mar 1;20(5):1192-202. doi: 10.1200/JCO.2002.20.5.1192. J Clin Oncol. 2002. PMID: 11870160

4

Trends in use of adjuvant multi-agent chemotherapy and tamoxifen for breast cancer in the United States: 1975-1999.

Mariotto A, Feuer EJ, Harlan LC, Wun LM, Johnson KA, Abrams J. Mariotto A, et al. Among authors: johnson ka. J Natl Cancer Inst. 2002 Nov 6;94(21):1626-34. doi: 10.1093/jnci/94.21.1626. J Natl Cancer Inst. 2002. PMID: 12419789

5

Improved survival time: what can survival cure models tell us about population-based survival improvements in late-stage colorectal, ovarian, and testicular cancer?

Huang L, Cronin KA, Johnson KA, Mariotto AB, Feuer EJ. Huang L, et al. Among authors: johnson ka. Cancer. 2008 May 15;112(10):2289-300. doi: 10.1002/cncr.23425. Cancer. 2008. PMID: 18393325 Free article.

6

Epidemiology of health disparities in relation to the biology of estrogen receptor-negative breast cancer.

Agurs-Collins T, Dunn BK, Browne D, Johnson KA, Lubet R. Agurs-Collins T, et al. Among authors: johnson ka. Semin Oncol. 2010 Aug;37(4):384-401. doi: 10.1053/j.seminoncol.2010.05.002. Semin Oncol. 2010. PMID: 20816508 Review.

7

Estimates of long-term survival for newly diagnosed cancer patients: a projection approach.

Mariotto AB, Wesley MN, Cronin KA, Johnson KA, Feuer EJ. Mariotto AB, et al. Among authors: johnson ka. Cancer. 2006 May 1;106(9):2039-50. doi: 10.1002/cncr.21803. Cancer. 2006. PMID: 16572414 Free article.

8

Prevention of ovarian cancer: intraepithelial neoplasia.

Brewer MA, Johnson K, Follen M, Gershenson D, Bast R Jr. Brewer MA, et al. Clin Cancer Res. 2003 Jan;9(1):20-30. Clin Cancer Res. 2003. PMID: 12538447 Review.

9

Health disparities in breast cancer: biology meets socioeconomic status.

Dunn BK, Agurs-Collins T, Browne D, Lubet R, Johnson KA. Dunn BK, et al. Among authors: johnson ka. Breast Cancer Res Treat. 2010 Jun;121(2):281-92. doi: 10.1007/s10549-010-0827-x. Epub 2010 May 1. Breast Cancer Res Treat. 2010. PMID: 20437200 Review.

10

Effects of obesity and race on prognosis in lymph node-negative, estrogen receptor-negative breast cancer.

Dignam JJ, Wieand K, Johnson KA, Raich P, Anderson SJ, Somkin C, Wickerham DL. Dignam JJ, et al. Among authors: johnson ka. Breast Cancer Res Treat. 2006 Jun;97(3):245-54. doi: 10.1007/s10549-005-9118-3. Epub 2005 Dec 6. Breast Cancer Res Treat. 2006. PMID: 16331345

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,824 results

Search Page